San Francisco 49ers and NetApp Team up to Elevate Operations and Fan Experience
Today, the San Francisco 49ers and NetApp® (NASDAQ: NTAP), the intelligent data infrastructure company, announced a new multi-year strategic partnership. Coming in as a founding level partner, the highest tier of 49ers corporate partnership, NetApp becomes the Official Intelligent Data Infrastructure Partner of the historic NFL franchise. Together, the two brands will utilize silo-free data infrastructure, built for intelligence, to support 49ers business operations throughout the organization, starting with the reimagination of the fan experience at Levi’s® Stadium.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250128057535/en/
George Kurian, CEO, NetApp and John Lynch, President of Football Operations/General Manager, San Francisco 49ers (Photo: Business Wire)
Rooted in Silicon Valley, both the 49ers and NetApp have a history of prioritizing technology, data, and innovation. As the 49ers enter the second decade of Levi’s® Stadium, the organization plans to make major tech enhancements to the venue with the goal of creating a new seamless and connected fan experience while laying a technology foundation that supports future growth and innovation for 49ers operations. Intelligent data infrastructure powered by NetApp solutions, including the NetApp Keystone storage-as-a-service offering, will expedite improvements to ingress and egress, bathroom and concession wait times, mobile app functionality, and more.
“When Levi’s® Stadium opened in 2014, it was one of the most technologically advanced stadiums in the country. While we have remained diligent in making improvements to the fan experience year over year, NetApp will empower us to make major changes that will bring the building into the forefront of technology-focused sports and entertainment venues,” said Costa Kladianos, 49ers EVP and Head of Technology.
“We are excited to welcome NetApp, a Bay Area brand and global leader in data infrastructure, as a founding level corporate partner,” said Brent Schoeb, 49ers Chief Revenue & Marketing Officer. “We look forward to integrating NetApp’s best-in-class, innovative technology across the 49ers and Levi’s® Stadium organization to enhance the fan experience.”
In addition to powering the 49ers’ goal of enhancing Levi’s® Stadium, NetApp has become the presenting sponsor of the 49ers 2025 NFL Draft, and the Levi’s® Stadium Owners Club, located on the East side of the building, will be renamed to recognize NetApp’s sponsorship. Finally, NetApp will be the presenting sponsor for the 49ers’ strategy, data, and analytics conference, Horizon Summit, returning to Levi’s® stadium in June 2025. Additional details about the sixth iteration of the event, including dates and confirmed speakers, will be announced in the coming months.
“By becoming an integral part of the 49ers' operations, NetApp is demonstrating our deep commitment to innovation, leadership, and excellence in Silicon Valley,” said George Kurian, CEO, NetApp. “Intelligent data infrastructure is crucial to the sports fan experience and team performance. Our support of the 49ers' ambitious goals for making its home stadium the benchmark for excellence in fan experience and team performance demonstrates our strong ties to our San Francisco Bay Area home and our unique capabilities to make data an asset in leading organizations achieving their transformation goals.”
For more information about the 49ers, please visit 49ers.com and LevisStadium.com.
Additional Resources
About the San Francisco 49ers
The San Francisco 49ers, owned by the York family, currently play in the NFC West division and have won five Super Bowl trophies including Super Bowl XVI, XIX, XXIII, XXIV and XXIX. The franchise also has eight conference championships and 22 divisional championships and was the first major league professional sports team to be based in San Francisco over 75 years ago. Please visit 49ers.com and follow the 49ers on Facebook and Twitter @49ers.
About NetApp
NetApp is the intelligent data infrastructure company, combining unified data storage, integrated data services, and CloudOps solutions to turn a world of disruption into opportunity for every customer. NetApp creates silo-free infrastructure, harnessing observability and AI to enable the industry’s best data management. As the only enterprise-grade storage service natively embedded in the world’s biggest clouds, our data storage delivers seamless flexibility. In addition, our data services create a data advantage through superior cyber resilience, governance, and application agility. Our CloudOps solutions provide continuous optimization of performance and efficiency through observability and AI. No matter the data type, workload, or environment, with NetApp you can transform your data infrastructure to realize your business possibilities. Learn more at www.netapp.com or follow us on X, LinkedIn, Facebook, and Instagram.
NETAPP, the NETAPP logo, and the marks listed at www.netapp.com/TM are trademarks of NetApp, Inc. Other company and product names may be trademarks of their respective owners.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250128057535/en/
Contacts
Media Contacts:
Kenya Hayes
NetApp
kenya.hayes@netapp.com
Jacob Fill
San Francisco 49ers
Jacob.Fill@49ers.com
Investor Contact:
Kris Newton
NetApp
kris.newton@netapp.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Coincheck Group N.V. to Announce Third Quarter 2025 Results on February 12, 202531.1.2025 15:30:00 EET | Press release
Coincheck Group N.V. (the “Company”) (Nasdaq: CNCK), the holding company for Coincheck, Inc, a leading Japanese crypto exchange, today announced that the Company will release its third quarter 2025 financial results on Wednesday, February 12, 2025. The Company will host a conference call to discuss third quarter 2025 financial results at 5:00 pm ET that same day. Hosting the call will be Oki Matsumoto, Executive Chairman, Gary Simanson, Chief Executive Officer, and Jason Sandberg, Chief Financial Officer. The call will be webcast live from the Company's website at www.coincheckgroup.com. A replay will be available on the Company’s investor relations website following the call. The conference call can also be accessed over the phone by dialing (877) 407-4018 or (201) 689-8471; the Conference ID is 13751285. About Coincheck Group N.V. Headquartered in the Netherlands, Coincheck Group N.V. (NASDAQ: CNCK) is a public limited liability company and the holding company for Coincheck, Inc. Coi
Datopotamab Deruxtecan Recommended for Approval in the EU by CHMP for Patients with Previously Treated Metastatic HR Positive, HER2 Negative Breast Cancer31.1.2025 15:00:00 EET | Press release
Datopotamab deruxtecan (Dato-DXd) has been recommended for approval in the European Union (EU) for the treatment of adult patients with unresectable or metastatic hormone receptor (HR) positive, HER2 negative (IHC 0, IHC 1+ or IHC 2+/ISH-) breast cancer who have received endocrine therapy and at least one line of chemotherapy in the advanced setting. Datopotamab deruxtecan is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE:45680) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/Nasdaq: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the TROPION-Breast01 phase 3 trial published in the Journal of Clinical Oncology. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In TROPION-Breast01, datopot
REPLY: Coding and Cybersecurity, Registration Is Now Open for the Reply Hack The Code Challenge 202531.1.2025 13:42:00 EET | Press release
Reply has announced the opening of registrations for the ReplyHackThe Code Challenge 2025, the leading online team coding competition, which will take place on March 12th 2025. This year's challenge will combine programming and cybersecurity for the first time, offering participants the opportunity to tackle algorithmic problems and cybersecurity challenges. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250131992792/en/ Reply has announced the opening of registrations for the Reply Hack The Code Challenge 2025, the leading online team coding competition, which will take place on March 12th 2025. This year's challenge will combine programming and cybersecurity for the first time, offering participants the opportunity to tackle algorithmic problems and cybersecurity challenges. (Photo: Business Wire) The competition follows the format of previous events, with two parallel challenges: the Standard Edition, aimed at university
GE HealthCare Invests $138 Million in Cork, Ireland Manufacturing Facility to Address Increasing Contrast Media Demand31.1.2025 10:00:00 EET | Press release
GE HealthCare (Nasdaq: GEHC) today announced a $138 million investment to expand its Carrigtohill, Cork contrast media fill and finish manufacturing site in Ireland. A new state-of-the-art facility on the grounds of the existing site will enable 25 million more patient doses per year of contrast media by the end of 2027, helping address growing global demand. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250130241464/en/ GE HealthCare’s contrast media manufacturing site in Cork (Photo: Business Wire) Contrast media are injectable diagnostic imaging agents used to enhance visualization of organs, blood vessels and tissues during medical imaging. Global demand for iodine-based contrast media, used in X-Ray, Computed Tomography (CT) and Interventional procedures is expected to double in the next decade, driven by ageing populations and the increasing global prevalence of chronic disorders. In 2024, the Carrigtohill facility, a
Vertex Announces CASGEVY ® Reimbursement Agreement for the Treatment of Sickle Cell Disease in England31.1.2025 09:00:00 EET | Press release
Vertex Pharmaceuticals (Nasdaq: VRTX) announced today a reimbursement agreement with NHS England for eligible sickle cell disease (SCD) patients to access the CRISPR/Cas9 gene-edited therapy, CASGEVY® (exagamglogene autotemcel). The reimbursement agreement comes as the National Institute for Health and Care Excellence (NICE) issues positive guidance recommending CASGEVY’s use in the NHS. It means that eligible SCD patients in England now have access to the therapy following the prior agreement for transfusion-dependent beta thalassemia (TDT) patients announced last August. “Today is an important day for the sickle cell community who have gone too long without treatments that address the underlying cause of their devastating disease,” said Ludovic Fenaux, Senior Vice President, Vertex International. “We are pleased to have reached this new agreement that ensures both eligible SCD and TDT patients can now be treated with CASGEVY, recognizing the value a one-time treatment can provide to
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom